These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 19222150)
1. Last fall I began taking daily doses of 1,500 mg of niacin, in addition to the 40 mg of Lipitor I've been taking for several years. Within six months, my LDL and triglycerides were down significantly and my HDL was higher. If my next bi-annual blood test shows the same types of results, should I discontinue the Lipitor and niacin? Heart Advis; 2008 Sep; 11(9):8. PubMed ID: 19222150 [No Abstract] [Full Text] [Related]
2. Reply to Al-Shaer, is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome? (Am Heart J 2005;149:e17.). Milionis HJ; Elisaf MS Am Heart J; 2005 Jul; 150(1):e7. PubMed ID: 16084140 [No Abstract] [Full Text] [Related]
3. I've taken Lipitor since my first heart attack two years ago, and my LDL has dropped steadily to 140. Given the new LDL guidelines, though, just how am I supposed to go about slashing it to a level of 70? Health News; 2004 Sep; 10(9):16. PubMed ID: 15597458 [No Abstract] [Full Text] [Related]
4. I've heard that high-fat foods and alcohol can raise triglyceride levels. I take Lipitor for high cholesterol, don't eat high-fat foods and don't drink alcohol except for half a glass of wine a few times a month. My triglycerides are always high when checked--my last reading was 222. What else can I do to help lower my triglycerides? Duke Med Health News; 2009 Jul; 15(7):8. PubMed ID: 19681192 [No Abstract] [Full Text] [Related]
5. [Low HDL-cholesterol, high triglycerides--well known but often ignored]. Benz R; Suter PM Praxis (Bern 1994); 2004 Nov; 93(46):1911-6. PubMed ID: 15580883 [TBL] [Abstract][Full Text] [Related]
6. By the way, doctor... My brother takes Mevacor and has been told to take the drug at bedtime. But when I started on Lipitor, my doctor said to take the medication at any time of the day. Why the difference? Lee TH Harv Health Lett; 2001 Aug; 26(10):8. PubMed ID: 11546623 [No Abstract] [Full Text] [Related]
7. Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g). Alrasadi K; Awan Z; Alwaili K; Ruel I; Hafiane A; Krimbou L; Genest J Am J Cardiol; 2008 Nov; 102(10):1341-7. PubMed ID: 18993152 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia. Goldberg AC; Bays HE; Ballantyne CM; Kelly MT; Buttler SM; Setze CM; Sleep DJ; Stolzenbach JC Am J Cardiol; 2009 Feb; 103(4):515-22. PubMed ID: 19195513 [TBL] [Abstract][Full Text] [Related]
9. After I had a heart attack and two bypass operations, I was put on Lipitor to lower my cholesterol. My cholesterol was never high--about 170-180 mg/dL. But my HDL was always low and triglycerides were somewhat high. Now my total cholesterol is 124 and my HDL has gone up slightly. My triglycerides are way down. My LDL cholesterol has fallen from 110 to 68. Is there any downside to such a low cholesterol level, other than the need to check my liver function tests? Lee TH Harv Heart Lett; 1999 Jan; 9(5):7. PubMed ID: 9916564 [No Abstract] [Full Text] [Related]
10. High-dose atorvastatin therapy achieves 25% reduction in CV events in TNT substudy of diabetic patients. Cardiovasc J S Afr; 2006; 17(4):206-7. PubMed ID: 17001426 [No Abstract] [Full Text] [Related]
11. [Hypercholesterolemia and control with therapy]. von Eckardstein A Praxis (Bern 1994); 2007 Apr; 96(15):583. PubMed ID: 17506387 [No Abstract] [Full Text] [Related]
12. I'm taking Zocor to help lower my cholesterol. The directions say to take it at night. My friend takes Lipitor, but doesn't have to take it at night. Why the difference? Mayo Clin Health Lett; 2005 Dec; 23(12):8. PubMed ID: 16444809 [No Abstract] [Full Text] [Related]
13. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol. Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310 [TBL] [Abstract][Full Text] [Related]
14. Lipid modifying action of atorvastatin in comparison to combination of atorvastatin and nicotinic acid in patients with ischaemic heart disease. Santanu G; Suhrita P; Mookerjee S; Tania K; Mita S; Pramit G; Sharmila G; Miraj M; Debdutta M Indian Heart J; 2011; 63(5):434-7. PubMed ID: 23550422 [TBL] [Abstract][Full Text] [Related]
15. A multicenter, eight-week treatment, single-step titration, open-label study assessing the percentage of Korean dyslipidemic patients achieving LDL cholesterol target with atorvastatin starting doses of 10 mg, 20 mg and 40 mg. Lee CW; Baek SH; Hong TJ; Choi YJ; Kim YJ; Ahn TH; Ihm SH; Bae JH; Hong SJ; Kim DI; Ahn YK; Hur SH; Park DG; Choi DJ; Lee SU; Kim BS; Ryu KH; Jang YS; Lee SH; Seung KB; Kim HS Cardiovasc Drugs Ther; 2010 Apr; 24(2):181-8. PubMed ID: 20383571 [TBL] [Abstract][Full Text] [Related]
16. [Assessment of hypolipidemic efficacy and safety of various doses of atorvastatin]. Kukharchuk VV; KaminnÄ AI Kardiologiia; 2007; 47(10):51-3. PubMed ID: 18260944 [No Abstract] [Full Text] [Related]
17. Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia. Tomassini JE; Mazzone T; Goldberg RB; Guyton JR; Weinstock RS; Polis A; Jensen E; Tershakovec AM Diabetes Obes Metab; 2009 Sep; 11(9):855-64. PubMed ID: 19508464 [TBL] [Abstract][Full Text] [Related]
18. [CME-Lab 2/Solution. Hypercholesteremia and therapy control]. von Eckardstein A Praxis (Bern 1994); 2007 Apr; 96(17):701-2. PubMed ID: 17491201 [No Abstract] [Full Text] [Related]
19. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Ballantyne CM; Houri J; Notarbartolo A; Melani L; Lipka LJ; Suresh R; Sun S; LeBeaut AP; Sager PT; Veltri EP; Circulation; 2003 May; 107(19):2409-15. PubMed ID: 12719279 [TBL] [Abstract][Full Text] [Related]
20. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia. Karalis DG; Ishisaka DY; Luo D; Ntanios F; Wun CC Am J Cardiol; 2007 Aug; 100(3):445-9. PubMed ID: 17659926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]